{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:51:57Z","timestamp":1790913117160,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.biopha.2018.03.062","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T01:22:41Z","timestamp":1522977761000},"page":"1099-1104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Sodium butyrate abolishes the degradation of type II collagen in human chondrocytes"],"prefix":"10.1016","volume":"102","author":[{"given":"Wang","family":"Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2018.03.062_bib0005","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar4599","article-title":"Protective role of frizzled-related protein B on matrix metalloproteinase induction in mouse chondrocytes","volume":"16","author":"Bougault","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.03.062_bib0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/ar326","article-title":"Articular cartilage and changes in arthritis: noncollagenous proteins and proteoglycans in the extracellular matrix of cartilage","volume":"3","author":"Roughley","year":"2001","journal-title":"Arthritis Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.03.062_bib0015","doi-asserted-by":"crossref","first-page":"e2851","DOI":"10.1038\/cddis.2017.215","article-title":"In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects","volume":"8","author":"Jiang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2018.03.062_bib0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.blo.0000144166.66737.3a","article-title":"Matrix metalloproteinases and their clinical applications in orthopaedics","volume":"428","author":"Bramono","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.biopha.2018.03.062_bib0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbrc.2012.12.094","article-title":"Human YKL39 (chitinase 3-like protein 2), an osteoarthritis-associated gene, enhances proliferation and type II collagen expression in ATDC5 cells","volume":"431","author":"Miyatake","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.03.062_bib0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2013.12.007","article-title":"Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes","volume":"19","author":"Chen","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl. II","key":"10.1016\/j.biopha.2018.03.062_bib0035","doi-asserted-by":"crossref","first-page":"ii78","DOI":"10.1136\/ard.61.suppl_2.ii78","article-title":"Type II collagen degradation and its regulation in articular cartilage in osteoarthritis","volume":"61","author":"Poole","year":"2002","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.biopha.2018.03.062_bib0040","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2013","article-title":"Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage","volume":"8","author":"Davidson","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2018.03.062_bib0045","doi-asserted-by":"crossref","first-page":"30576","DOI":"10.1074\/jbc.273.46.30576","article-title":"Differential expression of aggrecanase and matrix metalloproteinase activity in chondrocytes isolated from bovine and porcine articular cartilage","volume":"273","author":"Hughes","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.03.062_bib0050","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1172\/JCI114215","article-title":"Evidence for metalloproteinase and metallopro- teinase inhibitor imbalance in human osteoarthritic cartilage","volume":"84","author":"Dean","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.03.062_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.joca.2013.10.016","article-title":"Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1b induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes","volume":"22","author":"Dunn","year":"2014","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.biopha.2018.03.062_bib0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbrc.2003.08.026","article-title":"Butyrate modulates gene and protein expression in human intestinal endothelial cells","volume":"309","author":"Ogawa","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2018.03.062_bib0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12974-017-0807-8","article-title":"The potential neuroprotective role of a histone deacetylase inhibitor, sodium butyrate, after neonatal hypoxia-ischemia","volume":"14","author":"Jaworska","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.biopha.2018.03.062_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2018.03.062_bib0075","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.0408345102","article-title":"Apoptotic and autophagic cell death induced by histone deacetylase inhibitors","volume":"101","author":"Shao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.03.062_bib0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12974-016-0765-6","article-title":"The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats","volume":"13","author":"Park","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.biopha.2018.03.062_bib0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5551\/jat.15065","article-title":"Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages","volume":"20","author":"Ohira","year":"2013","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.biopha.2018.03.062_bib0090","first-page":"4157","article-title":"Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors","author":"Vincenti","year":"2002","journal-title":"Arthritis Res."},{"issue":"20","key":"10.1016\/j.biopha.2018.03.062_bib0095","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2018.03.062_bib0100","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/art.24303","article-title":"Activation of cartilage matrix metalloproteinases by activated protein C","volume":"60","author":"Jackson","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.biopha.2018.03.062_bib0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/aps.2013.128","article-title":"Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-\u03baB pathway","volume":"35","author":"Ge-fei","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2018.03.062_bib0110","doi-asserted-by":"crossref","first-page":"464161","DOI":"10.1155\/2015\/464161","article-title":"Millimeter wave treatment inhibits apoptosis of chondrocytes via regulation dynamic equilibrium of intracellular free Ca (2+)","volume":"2015","author":"Ye","year":"2015","journal-title":"Evid Based Complement Altern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.03.062_bib0115","first-page":"111","article-title":"Tissue inhibitors of metalloproteinases: structure, regulation and biological functions","volume":"74","author":"Gomez","year":"1997","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.biopha.2018.03.062_bib0120","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nm.2153","article-title":"Hypoxia-inducible factor-2\u03b1 is a catabolic regulator of osteoarthritic cartilage destruction","volume":"16","author":"Yang","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2018.03.062_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.biopha.2018.03.062_bib0130","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3892\/ijmm.2012.1135","article-title":"Sphingosine-1-phosphate inhibits interleukin-1\u03b2-induced inflammation in human articular chondrocytes","volume":"30","author":"Moon","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2018.03.062_bib0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/ar401","article-title":"Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors","volume":"4","author":"Vincenti","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.biopha.2018.03.062_bib0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrm763","article-title":"Matrixmetalloproteinases: a tail of a frog that became a prince","volume":"3","author":"Brinckerhoff","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2018.03.062_bib0145","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1186\/ar572","article-title":"Matrix metalloproteinases in arthritic disease","volume":"4","author":"Murphy","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.biopha.2018.03.062_bib0150","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/0929867013373417","article-title":"The design, structure, and therapeutic application of matrix metalloproteinase inhibitors","volume":"8","author":"Skiles","year":"2001","journal-title":"Curr. Med. Chem."},{"issue":"August","key":"10.1016\/j.biopha.2018.03.062_bib0155","first-page":"11","article-title":"The short-chain fatty acid sodium butyrate exerts protective effects through ameliorating blood-milk barrier disruption and modulating inflammatory response in lipopolysaccharide-induced mastitis model","author":"Wang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.03.062_bib0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, andattenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2018.03.062_bib0165","doi-asserted-by":"crossref","first-page":"24838","DOI":"10.1038\/srep24838","article-title":"Microbial metabolite butyrate facilitates M2 macrophage polarization and function","volume":"6","author":"Ji","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2018.03.062_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/j.1460-2075.1993.tb05646.x","article-title":"Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus","volume":"12","author":"Zabel","year":"1993","journal-title":"EMBO J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217359139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217359139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:00:42Z","timestamp":1731427242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217359139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":34,"alternative-id":["S0753332217359139"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.062","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium butyrate abolishes the degradation of type II collagen in human chondrocytes","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.03.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}